{"paper_id":"203291e2-5682-4109-8183-f17cef0eea61","body_text":"Abstract\nIn this evaluation, the first part evaluates three different treatment strategies (hormonal medication, surgical treatment, or combined treatment) and discusses the influence of endometriosis on pregnancy outcome. Four hundred and fifty patients with genital endometriosis, aged 18–44 years, were randomly distributed to three treatment groups at the first laparoscopy. They were reevaluated at a second-look laparoscopy (D 426/10), 1–2 months after the 3-month hormonal therapy for groups 1 and 3 and 5–6 months later for group 2 (surgical treatment alone). Outcome data focused on the recurrence and pregnancy rate.\nThe three treatment options—independent of the initial endoscopic endometriosis classification (EEC) stage including deep infiltrating endometriosis (DIE)—achieved an overall cure rate of 50% or higher. The highest cure rate of 60% was achieved by the combined treatment, 55% by the exclusive hormonal therapy, and 50% by the exclusive surgical treatment. An overall pregnancy rate between 55 and 65% was achieved with no significant difference in relation to the therapeutical option.\nFurther we consider in the second part the relation of pregnancy and endometriosis with the following conclusions: (1) increased risk for premature deliveries and pregnancy complications, (2) more frequent preeclampsia and antepartum hemorrhage, (3) increased rate of Cesarean sections, (4) severe pain in pregnancy continues in quite a few patients, and (5) obstetricians should be aware of obstetric emergencies, such as direct bleeding from lesions, bleeding from uterine arteries or veins, interruption of ureter, and severe peritoneal decidualized endometriosis.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nJohnson NP, Hummelshoj L. Consensus on current management of endometriosis. Hum Reprod. 2013;28(6):1552–68.\nHughes E, et al. Ovulation suppression for endometriosis. Cochrane Database Syst Rev. 2007;(3):CD000155.\nStrowitzki T, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod. 25(3):633–41.\nZupi E, et al. Add-back therapy in the treatment of endometriosis-associated pain. Fertil Steril. 2004;82(5):1303–8.\nWong CL, et al. Oral contraceptive pill as treatment for primary dysmenorrhoea. Cochrane Database Syst Rev. 2009;(2):CD002120.\nDavis L, et al. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev. 2007;(3):CD001019.\nMousa NA, Bedaiwy MA, Casper RF. Aromatase inhibitors in the treatment of severe endometriosis. Obstet Gynecol. 2007;109(6):1421–3.\nFerrero S, et al. Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis. Hum Reprod. 2009;24(12):3033–41.\nMettler L, et al. Challenges of endometriosis. Eur Obstet Gynecol. 2011;6(2):83–90.\nOlive DL, Schwartz LB. Endometriosis. N Engl J Med. 1993;328(24):1759–69.\nKennedy S, et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod. 2005;20(10):2698–704.\nStegmann BJ, et al. Using location, color, size, and depth to characterize and identify endometriosis lesions in a cohort of 133 women. Fertil Steril. 2008;89(6):1632–6.\nWykes CB, Clark TJ, Khan KS. Accuracy of laparoscopy in the diagnosis of endometriosis: a systematic quantitative review. BJOG. 2004;111(11):1204–12.\nChristensen B, Freie HM, Schindler AE. Endometriosis—diagnosis and therapy. Results of a current survey of 6,700 gynecologists. Geburtshilfe Frauenheilkd. 1995;55(12):674–9.\nMedicine PCoASfR. Treatment of pelvic pain associated with endometriosis. Fertil Steril. 2008;90(5 Suppl):S260–9.\nBuchweitz O, et al. The diagnostic dilemma of minimal and mild endometriosis under routine conditions. J Am Assoc Gynecol Laparosc. 2003;10(1):85–9.\nMettler L, Schollmeyer T, Alkatout I. Adhesions during and after surgical procedures, their prevention and impact on women's health. Women's Health (Lond Engl). 2012;8(5):495–8.\nAlkatout I, et al. Endometriose: Medikamentöse und operative Therapieoptionen. gynäkologie + geburtshilfe. 2013;18(1):38–45.\nAbbott J, et al. Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril. 2004;82(4):878–84.\nHealey M, Ang WC, Cheng C. Surgical treatment of endometriosis: a prospective randomized double-blinded trial comparing excision and ablation. Fertil Steril. 2010;94(7):2536–40.\nJacobson TZ, et al. Laparoscopic surgery for pelvic pain associated with endometriosis. Cochrane Database Syst Rev. 2001;(4):CD001300.\nCrosignani PG, et al. Laparoscopy versus laparotomy in conservative surgical treatment for severe endometriosis. Fertil Steril. 1996;66(5):706–11.\nTaylor E, Williams C. Surgical treatment of endometriosis: location and patterns of disease at reoperation. Fertil Steril. 2010;93(1):57–61.\nYeung PP Jr, Shwayder J, Pasic RP. Laparoscopic management of endometriosis: comprehensive review of best evidence. J Minim Invasive Gynecol. 2009;16(3):269–81.\nEngemise S, Gordon C, Konje JC. Endometriosis. BMJ. 2010;340:c2168.\nAlkatout I, et al. Combined surgical and hormone therapy for endometriosis is the most effective treatment: prospective, randomized, controlled trial. J Minim Invasive Gynecol. 2013;20(4):473–81.\nMettler L. Diagnostik und Therapie der Endometriose. Eur Secur. 1984;5:234–40.\nMettler L, Semm K. Three step medical and surgical treatment of endometriosis. Ir J Med Sci. 1983;152(Suppl 2):26–8.\nStephansson O, et al. Endometriosis, assisted reproduction technology, and risk of adverse pregnancy outcome. Hum Reprod. 2009;24(9):2341–7.\nBrosens I, et al. The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders? Hum Reprod. 2010;25(3):569–74.\nHadfield RM, et al. Is there an association between endometriosis and the risk of pre-eclampsia? A population based study. Hum Reprod. 2009;24(9):2348–52.\nWood R. Myths and misconceptions in endometriosis.\nMettler L, et al. Identification of the M-CSF receptor in endometriosis by immunohistochemistry and RT-PCR. Am J Reprod Immunol. 2004;52(5):298–305.\nMettler L, et al. Comparison of c-DNA microarray analysis of gene expression between eutopic endometrium and ectopic endometrium (endometriosis). J Assist Reprod Genet. 2007;24(6):249–58.\nSampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into peritoneal cavity. Am J Obstet Gynecol. 1927;14:422–69.\nEbert AD, editor. Endometriose. Berlin: Walther de Gruyter Verlag; 2003.\nSchweppe KW, et al., editors. Endometriose: Entstehung, Diagnostik, Behandlungsmöglichkeiten und Probleme in Klinik und Praxis. Heidelberg: Seminar in Gynäkologische Endokrinologie; 2012. p. 516–34.\nAdamson GD, Pasta DJ. Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril. 2010;94(5):1609–15.\nYap C, Furness S, Farquhar C. Pre and post operative medical therapy for endometriosis surgery. Cochrane Database Syst Rev. 2004;(3):CD003678.\nSeracchioli R, et al. Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis. Hum Reprod. 2009;24(11):2729–35.\nSchweppe KW. Therapie der Endometriose unter Berücksichtigung der Aktivitätsgrade. Gynakologe. 2002;35:255–61.\nSchindler AE, et al. Treatment of endometriosis with the GnRH agonist buserelin (Suprecur): a multicenter study. Geburtshilfe Frauenheilkd. 1994;54(10):569–73.\nRegidor PA, et al. Treatment of endometriosis with the GnRH analog triptorelin with special reference to the effect on bone density. Zentralbl Gynakol. 1993;115(11):473–7.\nRaitz von Frentz M, Schweppe KW. Ovarian suppression by the GnRH analog buserelin in the treatment of endometriosis. Clinical, biochemical and pelviscopic studies. Geburtshilfe Frauenheilkd. 1990;50(8):634–9.\nRomer T, Schwesinger G. Wie durchbricht man den Teufelskreis der aktiven Endometriose? Neue Aspekte der Therapieentscheidung bei aktiver Endometriose. Zentralbl Gynakol. 1999;121(7):336–40.\nRegidor PA, et al. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis. Gynecol Endocrinol. 2001;15(3):202–9.\nGuzick DS, et al. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain. Fertil Steril. 2011;95(5):1568–73.\nSutton CJ, et al. Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril. 1994;62(4):696–700.\nCahill DJ. What is the optimal medical management of infertility and minor endometriosis? Analysis and future prospects. Hum Reprod. 2002;17(5):1135–40.\nMarcoux S, Maheux R, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. N Engl J Med. 1997;337(4):217–22.\nBarcena de Arellano ML, et al. Overexpression of nerve growth factor in peritoneal fluid from women with endometriosis may promote neurite outgrowth in endometriotic lesions. Fertil Steril. 2011;95(3):1123–6.\nKeichel S, et al. Lymphangiogenesis in deep infiltrating endometriosis. Hum Reprod. 2011;26(10):2713–20.\nSomigliana E, Vigano P, Vignali M. Endometriosis and unexplained recurrent spontaneous abortion: pathological states resulting from aberrant modulation of natural killer cell function? Hum Reprod Update. 1999;5(1):40–51.\nChiodo I, et al. Urohemoperitoneum during pregnancy with consequent fetal death in a patient with deep endometriosis. J Minim Invasive Gynecol. 2008;15(2):202–4.\nWada S, et al. Uterine vein rupture at delivery as a delayed consequence of laparoscopic surgery for endometriosis: a case report. J Minim Invasive Gynecol. 2009;16(4):510–2.\nFalcao JJ, SJ WE. Endometriosis in obstetric emergency. Free Communications and Posters, P1–108, in 11 th World Congress of Endometriosis, Montpellier, France, 4–7 September 2011.\nMabrouk M, et al. Spontaneous postpartum hemoperitoneum in primipara with decidualized pelvic endometriosis. Free Communication and Posters, P1–112, in 11 th World Congress on Endometriosis, Montpellier, France, 4–7 September 2011.\nMettler L, et al. Accuracy of laparoscopic diagnosis of endometriosis. JSLS. 2003;7(1):15–8.\nda Silva-Filho AL, Ferreira MCF, Lamaita RM, Rocha ALL, Cândido EB, Carneiro MM. Endometriosis and ovarian cancer: from molecular evidences to clinical implications. Journal of Endometr. 2016;8(3):81–6. https://doi.org/10.5301/je.5000248.\nBluett R, Fonseca-Kelly Z, Burke C. Efficacy of surgical intervention for the treatment of pain and improvement of quality of life in patients with endometriosis. J Endometr. 2016;8(3):101–5. https://doi.org/10.5301/je.5000246.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2018 IAHR (International Academy of Human Reproduction)\nAbout this chapter\nCite this chapter\nMettler, L., Alkatout, I. (2018). Human Reproduction: From State of the Art to Future Developments “Endometriosis Therapeutic Approaches”. In: Schenker, J., Sciarra, J., Mettler, L., Genazzani, A., Birkhaeuser, M. (eds) Reproductive Medicine for Clinical Practice. Reproductive Medicine for Clinicians, vol 1. Springer, Cham. https://doi.org/10.1007/978-3-319-78009-2_2\nDownload citation\nDOI: https://doi.org/10.1007/978-3-319-78009-2_2\nPublished:\nPublisher Name: Springer, Cham\nPrint ISBN: 978-3-319-78008-5\nOnline ISBN: 978-3-319-78009-2\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}